International AIDS Vaccine Initiative Harvard Case Solution & Analysis

Dedicated to speeding up the development of a safe, powerful, accessible, preventive HIV vaccine, the International AIDS Vaccine Initiative (IAVI) initiated methods of addressing the insufficient incentive arrangements that prevented advancement toward vaccines for AIDS and other diseases predominantly affecting poor people in tropical nations. As an mediator nonprofit association, IAVI brought together associates from nonprofit, business, government and scientific research sectors with different viewpoints and motivations toward developing vaccines.

IAVI played several parts: communicator and honest agent, integrator of knowledge regarding AIDS vaccine research, enthusiastic advocate for AIDS vaccines at national and international levels, and coordinator and manager of research and development initiatives. In 2008, IAVI invested in its own laboratories and research infrastructure, moving in vaccine development partnerships and clinical research. How should IAVI manage tensions between what is needed to construct new incentive structures that enable key actors to work together efficiently and what is crucial to realize its mission?

PUBLICATION DATE: November 04, 2009 PRODUCT #: 310015-PDF-ENG

This is just an excerpt. This case is about LEADERSHIP & MANAGING PEOPLE

International AIDS Vaccine Initiative Case Solution Other Similar Case Solutions like

International AIDS Vaccine Initiative

Share This